Beike Bio-Technology
China - ShenzhenBiotechnology
Focus: Beike Bio-Technology is a China-based stem cell therapy specialist focused on cell-based regenerative medicine, operating at mid-cap scale with 501-1000 employees since 2005.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
501-1000
Open Jobs
0
About Beike Bio-Technology
AI assessmentNot HiringNo open roles listed right now. Follow Beike Bio-Technology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
human umbilical cord mesenchymal stem cells
Progressive Multiple SclerosisClinical Trials (5)
NCT01443689Allogenic Stem Cell Therapy in Patients With Acute Burn
Phase 1/2Help build intelligence for Beike Bio-Technology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.